Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.92 USD
−615.06 M USD
86.18 M USD
87.38 M
About Vir Biotechnology, Inc.
Sector
Industry
CEO
Marianne de Backer
Website
Headquarters
San Francisco
Founded
2016
FIGI
BBG00H2QQ8T5
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VIR is 6.87 USD — it has decreased by −2.74% in the past 24 hours. Watch Vir Biotechnology, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Vir Biotechnology, Inc. stocks are traded under the ticker VIR.
VIR stock has fallen by −27.91% compared to the previous week, the month change is a −11.55% fall, over the last year Vir Biotechnology, Inc. has showed a −28.64% decrease.
We've gathered analysts' opinions on Vir Biotechnology, Inc. future price: according to them, VIR price has a max estimate of 110.00 USD and a min estimate of 10.00 USD. Watch VIR chart and read a more detailed Vir Biotechnology, Inc. stock forecast: see what analysts think of Vir Biotechnology, Inc. and suggest that you do with its stocks.
VIR stock is 5.34% volatile and has beta coefficient of 0.81. Track Vir Biotechnology, Inc. stock price on the chart and check out the list of the most volatile stocks — is Vir Biotechnology, Inc. there?
Today Vir Biotechnology, Inc. has the market capitalization of 928.23 M, it has decreased by −21.99% over the last week.
Yes, you can track Vir Biotechnology, Inc. financials in yearly and quarterly reports right on TradingView.
Vir Biotechnology, Inc. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
VIR earnings for the last quarter are −1.56 USD per share, whereas the estimation was −1.05 USD resulting in a −48.22% surprise. The estimated earnings for the next quarter are −0.87 USD per share. See more details about Vir Biotechnology, Inc. earnings.
Vir Biotechnology, Inc. revenue for the last quarter amounts to 2.38 M USD, despite the estimated figure of 5.54 M USD. In the next quarter, revenue is expected to reach 8.17 M USD.
VIR net income for the last quarter is −213.72 M USD, while the quarter before that showed −138.38 M USD of net income which accounts for −54.44% change. Track more Vir Biotechnology, Inc. financial stats to get the full picture.
No, VIR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 587.00 employees. See our rating of the largest employees — is Vir Biotechnology, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Vir Biotechnology, Inc. EBITDA is −524.78 M USD, and current EBITDA margin is −744.43%. See more stats in Vir Biotechnology, Inc. financial statements.
Like other stocks, VIR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Vir Biotechnology, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Vir Biotechnology, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Vir Biotechnology, Inc. stock shows the sell signal. See more of Vir Biotechnology, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.